New York State Common Retirement Fund Cyclerion Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$2.73 - $4.13 $554 - $838	-203 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$2.18 - $4.29 $25,870 - $50,909	-11,867 Reduced 98.32%	203 $1,000
Q1 2021 May 11, 2021	SELL	$2.69 - $5.12 $327,208 - $622,791	-121,639 Reduced 90.97%	12,070 $34,000
Q4 2020 Feb 08, 2021	SELL	$2.25 - $7.12 $18,675 - $59,096	-8,300 Reduced 5.84%	133,709 $409,000
Q2 2020 Aug 07, 2020	BUY	$2.37 - $7.14 $46,452 - $139,944	19,600 Added 16.01%	142,009 $839,000
Q1 2020 May 06, 2020	SELL	$2.46 - $5.84 $57,564 - $136,656	-23,400 Reduced 16.05%	122,409 $324,000
Q2 2019 Aug 09, 2019	BUY	$9.6 - $22.85 $1.4 Million - $3.33 Million	145,809 New	145,809 $1.67 Million

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $137M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.